Clinical Aspects of Renal Cell Carcinoma

Kirkali, Ziya; Öbek, Can

doi:10.1016/s1570-9124(03)00056-4

Cited by 22 publications

(11 citation statements)

References 87 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Other patients, even some with only localized disease, present with a wide array of symptoms and/or laboratory abnormalities. Because of this unusual characteristic, RCC has been labeled the "internist's tumor" [1]. Today, most tumors are diagnosed incidentally [6].…”

Section: Discussionmentioning

confidence: 99%

“…It was named after him as Grawitz tumor, or hyper nephroma, according to his belief that the tumor originated in adrenal rests at the upper pole of the kidney. Later, the origin of this tumor in renal tubular cells was documented [1]. Accounting for 2% of all adult malignancies [2], RCC has tendency to spread into the renal vein and the IVC (inferior vena cava).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

A Case Report of Large Renal Cell Carcinoma

TS¹,

Pn²

2012

J Clinic Case Reports

View full text Add to dashboard Cite

We report a case of 70 yr old woman with history of mass per abdomen since 5 months, which was insidious in onset and gradually progressed to present size. It was not associated with fever, haematuria, but gives history of loss of weight and loss of appetite. She was emaciated, poorly nourished with no significant past history. On examination she had mass per abdomen occupying Right lumbar, hypochondrium, umbilical, Right iliac fossa and hypogastrium abutting the anterior abdominal wall. No free fluid, no organomegaly. No evidence of swellings in other part of body, and no supraclavicular lymphadenopathy.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

A Case Report of Large Renal Cell Carcinoma

TS¹,

Pn²

2012

J Clinic Case Reports

View full text Add to dashboard Cite

show abstract

“…The region of interest (ROI) measured 60-100 mm 2 . Using the conventional axial T2WI and DWI images as a reference, the ROI was set at the same size in three successive levels of the ADC diagram, and the ADC was measured.…”

Section: Methodsmentioning

confidence: 99%

“…Renal cell carcinoma is the most common primary malignant tumor of the kidney, accounting for 85-90% of malignant kidney tumors (1) and 3% of all malignant tumors, with an incidence that is increasing yearly (2). Angiomyolipoma is the most common benign tumor of the kidney, comprising 7-9% of kidney tumors.…”

Section: Introductionmentioning

confidence: 99%

Diagnostic utility of diffusion-weighted magnetic resonance imaging in two common renal tumors

2015

View full text Add to dashboard Cite

Abstract. The aim of the present study was to evaluate the utility of diffusion-weighted magnetic resonance imaging (DWI) in the diagnosis of common renal tumors. Conventional magnetic resonance imaging and DWI were performed on 85 patients with renal lesions (54 renal carcinoma and 31 renal angiomyolipoma cases). The apparent diffusion coefficient (ADC) values in each case at b=800 sec/mm 2 were measured in the ADC maps using a statistical software package. The 54 cases of renal cell carcinoma showed a high signal intensity in the parenchyma, and the 31 renal angiomyolipoma cases showed a well-defined mixed signal intensity on DWI. The soft-tissue component showed a high signal intensity and the fat tissue showed a low signal intensity on DWI. When the b-value was set to 800 sec/mm 2 , the mean ADC was significantly lower in the renal carcinoma cases than in the renal angiomyolipoma cases. In conclusion, the measurement of ADC on DWI can reveal the structure of renal tumors, which is beneficial in diagnosing and determining the prognosis of benign and malignant renal tumors.

show abstract

“…It is estimated that approximately 25-30% of all patients with RCC have metastases at presentation, and even following complete resection of the primary tumour by radical nephrectomy, relapse occurs in 20-30% of patients (Whelan 2003). Those who present with metastasis have a 5-year survival of less than 10%; the overall 5-year survival rate is 60% (Kirkali and Oebek 2003).…”

Section: Introductionmentioning

confidence: 99%